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Abstract
Cell motility requires the temporal and spatial coordination of the actin cytoskeleton with cell-matrix
adhesions. Since their discovery more than 20 years ago, integrins have been at the center of cell-
matrix adhesion research. Integrin-mediated adhesions link the actin network to the extracellular
matrix and are commonly observed as cells migrate across rigid two-dimensional substrates.
However, as more cell motility studies are being conducted in three-dimensional (3D) culture
systems and in vivo, the role of integrins has become less clear. Recent work has shown that leukocyte




Integrins are a large family of heterodimeric cell-surface
receptors comprising one a and one b chain. To bind to
ligands, integrins must first undergo a conformation
change in a process known as activation [1]. In
leukocytes, these conformational changes can be
initiated by signaling downstream of other agonists
such as chemokines [2]. Activated integrins cluster on the
plasma membrane into small focal complexes or larger
focal adhesions that are associated with the actin
cytoskeleton [3,4]. Integrin-based adhesion complexes
can bind to either extracellular matrix proteins or
proteins present on the surface of other cells. By directly
connecting the cytoskeleton to surrounding matrix,
integrin-mediated adhesions permit contractile forces
to be directly applied to the adhesion to drive locomo-
tion [5]. Integrin complexes are capable of adhering
strongly to substrates; for example, the interaction
between integrin aLb2 (lymphocyte function-associated
antigen-1, or LFA-1) and intercellular adhesion
molecule-1 (ICAM-1) on endothelial cells is strong
enough for leukocytes to stick to endothelial cells in
the presence of shear forces [6,7]. The relationship
between adhesion and cell motility is complex: many
studies have shown that an intermediate amount of
adhesion is optimal for cell migration; too much
adhesion and cells cannot detach to move [8]. Con-
versely, if there is too little adhesion then cells cannot
generate sufficient traction for locomotion [8].
The role of leukocyte motility in immune responses
The recruitment of leukocytes from the circulation is
critical for an effective immune response. First, leuko-
cytes such as dendritic cells (DCs) need to move through
peripheral tissues to ‘scan’ for signs of infection. After
antigen uptake, they leave the tissue, enter lymphatic
vessels, and travel large distances to reach lymph nodes
[9]. Inside lymph nodes, cell motility continues in order
for the antigen-presenting DC to find and activate the
naïve T lymphocytes that recognise its unique major
histocompatibility complex (MHC)-peptide complex.
This process requires the scanning of thousands of
lymphocytes, which are also migrating in search of the
appropriate DC [10]. The activation of the lymphocyte
promotes its sustained proliferation, and the expanding
cohort of T lymphocytes leaves the lymph node and
travels to the site of infection to eliminate the potential
threat. The transit of these cells and other leukocytes to
sites of inflammation is largely through the blood.
Endothelial cells in inflamed tissues upregulate chemo-
kines and adhesion molecules such as selectins in
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order to recruit leukocytes [11]. Selectins mediate
intermediate-strength contacts with leukocytes that lead
to leukocytes rolling along the endothelium [12].
Subsequently, integrins become activated, leading to
the formation of firm adhesions that cause leukocyte
arrest [12]. The critical role for integrins in this process is
demonstrated by the immunodeficiency of patients with
defective integrin aLb2 (LFA-1) and Kindlin-3 [13]. Thus,
immune responses require cell motility to detect infec-
tion and for different cell types to meet and relay
messages and, finally, to respond to the threat [14].
For an effective immune response, cell motility must be
quick and efficient. Leukocytes move at speeds of greater
than 10 mm/minute, which are an order of magnitude
greater than the speed of cell types such as fibroblasts
and epithelial cells [15]. These differing speeds of
migration are also reflected in the differing organisation
of integrin-mediated adhesions on two-dimensional
(2D) substrates. Fibroblasts have large integrin-rich
focal adhesions that turn over in a time frame of
10-30 minutes [3,16]. The longevity of focal adhesions
would be incompatible with the high migration speeds
of leukocytes, and focal adhesions are not observed in
leukocytes. Instead, very transient integrin complexes are
present at the front of migrating leukocytes and a larger
focal zone of integrins is observed in the middle of the
cell [17]. Another challenge facing leukocytes is that they
migrate through varying tissues containing different
types of extracellular matrix. This problem could be
overcome by using integrins that can bind to a broad
range of ligands. Consistent with this notion, the
leukocyte integrin beta 2 can bind to numerous different
ligands, including plasma proteins (Factor X, C3bi,
fibrinogen, and fibronectin) [18], extracellular matrix
proteins (collagen and laminin) [19,20], and other
carbohydrate structures (including heparin-like glyco-
saminoglycans) [21]. Alternatively, adhesion molecules
besides integrins could be used. So what exactly is the
role of integrins in leukocyte migration?
Major recent advances
Integrins are dispensable in certain contexts
The role of integrins in the interstitial migration of
leukocytes was recently investigated by Lämmermann
and colleagues [22], who genetically deleted all known
integrin heterodimers and found that DCs were still able
to migrate from tissue to lymph nodes unimpeded.
Using two-photon microscopy, the authors confirmed
that the motile behaviour of DCs in the skin and lymph
nodes was indistinguishable from that of wild-type DCs
[22]. Furthermore, entry of DCs into lymphatic vessels
and movement through reconstituted three-dimensional
(3D) matrices were unchanged in the absence of
integrins [22]. These findings were not specific to DCs
as integrins were dispensable for the movement of
neutrophils and B cells in certain contexts. It has also
been reported that T cells can move in the presence of
integrin function-blocking antibodies [23]. However,
extravasation of integrin-null DCs from the bloodstream
to sites of inflammation was completely abolished,
underlining the critical role for integrins in immune
responses. The critical role of integrins in exit from the
blood probably reflects the need for strong adhesions to
counteract the shear stresses caused by blood flow. As
expected, integrin depletion severely compromised the
ability of leukocytes to adhere to ICAM-1 and fibronectin
and move in 2D environments. On first inspection, these
data suggest that the bi-phasic relationship of adhesion
strength and motility may not apply in 3D contexts [24].
However, it is worth noting that the assays used to
measure cell adhesion use planar 2D substrates that may
not accurately reflect adhesion in 3D environments.
The mechanism described for this integrin-independent
motility of DCs was critically dependent on actin
polymerisation. ROCK (Rho kinase)- and myosin
II-driven contraction of the actomyosin network was
needed to couple the zone of actin polymerisation at the
front of the cell to the nucleus and the rest of the cell
body [22]. Forces applied by the actomyosin cytoskele-
ton could also deform the nucleus to allow squeezing
through small spaces. This type of motility is similar to
that of amoeboid cancer cells [25]. Further work from the
same research group has shown a vital role of the small
Rho GTPase Cdc42 in the coordination of protrusive
activity required for efficient directional migration [26].
Undoubtedly, the mechanisms of leukocyte migration
through the interstitium in vivo are just the beginning to
be uncovered.
If integrins are dispensable for DC migration in some
3D environments, then how do the cells adhere to their
surroundings? An important observation by Lämmer-
mann and colleagues was that migration on a 2D plane
requires integrins whereas migration between two
2D planes does not. Therefore, a confined environment
is all that is needed to permit integrin-independent
motility. An exact explanation for this phenomenon is
not provided. One possibility is that, if a moving cell is
confined around its lateral edges, it can push outwards
and increase the friction provided by relatively weak
non-integrin interactions between the cell surface and
the confining substrates. The increased friction is then
sufficient for traction. Conceptually, this is similar to
the ‘chimneying’ technique used by climbers (Figure 1).
In the absence of confinement, the cell is unable
to effectively push against its substrate. The lateral
Page 2 of 5
(page number not for citation purposes)
F1000 Biology Reports 2009, 1:67 http://F1000.com/Reports/Biology/content/1/67
extension of protrusions into gaps in the matrix may also
provide some traction [27].
While the study of Lämmermann and colleagues
demonstrates that integrins are not needed for motility
in certain contexts, it does not demonstrate that wild-
type cells move without using their integrins or provide
alternative adhesion molecules. Insights into these issues
were provided by Woolf and colleagues [28] in a study of
T-cell migration within lymph nodes. The stromal cells
of the lymph node such as fibroblastic reticular cells
(FRCs) and the endothelium of the high endothelial
venules (HEVs) can present both immobilised chemo-
kines, such as chemokine (C-C motif) ligand-21
(CCL21), and integrin ligands such as VCAM-1 (vascular
cell adhesion molecule-1) and ICAM-1. However,
engagement of integrins within the lymph node could
lead to excess adhesion and T-cell arrest before they
encountered their specific antigen-presenting cell (APC),
resulting in an impaired immune response. To dissect
this issue, the roles of immobilised chemokines and
integrin ligands were investigated in vitro. It was found
that only immobilised chemokines were able to promote
sustained T-cell motility and that this did not require
additional adhesive signals such as integrin b1 engage-
ment [28]. Immobilised CCL21 could induce clustering
of integrin a4b1 (very late antigen-4, or VLA-4) and
integrin aLb2 (LFA-1) on T cells; critically, however,
although these integrins were clustered, they were not
adhesive [28]. Furthermore, integrin-blocking antibodies










man climbing a ladder
(good grip)
man trying to climb wall
(poor grip)
man trying to climb between two walls
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(a) Strong adhesions enable actin polymerisation to drive the front of the cell forward (analogous to a man climbing a ladder). The main limitation is
remodelling adhesions to enable the rear to follow. (b) If very weak adhesions are present, then there is insufficient friction and actin polymerisation cannot
push the cell forward (analogous to a man trying to climb a smooth wall). (c) Friction generated from weak adhesions can be increased if the cells are pushed
against substrate. This can happen in a confined environment (analogous to man climbing between two walls, or ‘chimneying’).
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could not prevent T lymphocytes moving within lymph
nodes. Therefore, in these contexts, wild-type cells appear
to move without using integrins, hence deletion of
integrins does not affect motility within lymph nodes
[22]. It is possible that the interaction between immo-
bilised CCL21 and its binding partners on the cell
surface, CCR7 [chemokine (C-C motif) receptor-7] and
PSGL-1 (P-selectin glycoprotein ligand-1), could provide
the adhesion necessary for cell migration, although this
has not been demonstrated. Adhesion through integrins
is induced only when the cells encounter shear forces in
addition to chemokine signaling, such as T cells would
encounter on the surface of HEVs when entering the
lymph node from the circulation. The lack of integrin
adhesiveness in the absence of shear flow has been
termed ‘integrin silencing’ and provides an answer to the
apparent contradiction of the presence of both integrin
ligands and chemokines on FRCs where T cells need to be
highly motile until they find their APC partner. Integrin
silencing also occurs in neutrophils moving on fibrino-
gen in the absence of shear stress [28], suggesting that it
may be a general mechanism in leukocytes. Integrin
silencing can be over-ridden by strong signaling through
the T-cell receptor [28]. Thus, once the T cell is presented
with its cognate antigen, strong adhesions stop it from
moving.
Future directions
Before these studies, it had been assumed that integrins
were critical for leukocyte motility in all contexts.
However, we now have a clearer framework of when
integrins are used and when they are not. In situations
in which cells need adhesions strong enough to halt
motile behaviour and anchor cells in one place, integrins
are critical. However, integrins are dispensable for
movement through tissues at high speeds and to ‘scan’
large numbers of potential partners in a lymph node.
Although integrins seem to be redundant in these
contexts, it does not mean that migrating leukocytes
do not require any form of adhesion. For actin
polymerisation-driven changes in cell morphology to
be successfully translated into locomotion, leukocytes
may employ alternative adhesion molecules with lower
affinities for their substrates. It is possible that chemo-
kine-receptor interactions may fulfill this role but this is
unproven as yet. These weaker adhesions would favour
more transient interactions with matrix proteins and
rapid cell motility. Integrins recruit a range of proteins to
their cytoplasmic tails that couple to F-actin and these
proteins enable the force generated by the actin
cytoskeleton to act on the extracellular matrix. It remains
to be determined how the actin cytoskeleton might
connect to non-integrin adhesions used by rapidly
migrating leukocytes. An effective immune response
requires leukocytes to use both types of motility and to
switch between them at the appropriate times. At
present, our insights into the molecular details of how
cells switch from integrin-dependent to -independent
modes of motility are limited. No doubt, the next few
years will yield answers to some of these issues and
generate new, unexpected and exciting questions.
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